Skip to main content
All lobbying filings

VENN STRATEGIES

VENN STRATEGIES filed a Q2 report for TRIS PHARMA, INC. on July 18, 2025, reporting $200,000 in lobbying income.

Lobbying for TRIS PHARMA, INC. · Biopharmaceutical company

All filings by VENN STRATEGIES · Everything TRIS PHARMA, INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 18, 2025
Income
$200,000
What the client paid this registrant for the period.
Client based in
New Jersey

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Policy activities related to treatment of ADHD.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem